50 Participants Needed

CEM-Plate and CEM-Cage Devices for Cervical Disc Disorder

Recruiting at 3 trial locations
EH
Overseen ByEric H Ledet, Ph.D.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial tests the safety and effectiveness of the CEM-Cage and CEM-Plate in patients needing a specific neck surgery. These devices help stabilize and fuse neck bones after damaged discs are removed. The study will monitor patients for an extended period to ensure successful healing and device performance.

Do I need to stop my current medications for the trial?

The trial information does not specify if you need to stop taking your current medications. However, if you are on high-dose steroids or investigational drugs, you may not be eligible to participate.

What data supports the effectiveness of the CEM-Plate and CEM-Cage treatment for cervical disc disorder?

Research on similar treatments, like cage-and-plate constructs, shows they are effective for stabilizing the cervical spine and restoring disc height in cervical disc disease. These treatments are commonly used and have been shown to help with conditions requiring cervical decompression and stabilization.12345

Is the CEM-Plate and CEM-Cage treatment safe for humans?

Research on similar devices, like cervical plates and cage systems used in spine surgeries, shows that they are generally safe. In one study, 48 adverse events were reported, but none were linked to the device itself, suggesting that these types of devices are typically safe for human use.13678

How is the CEM-Plate and CEM-Cage treatment for cervical disc disorder different from other treatments?

The CEM-Plate and CEM-Cage treatment is unique because it combines a plate and cage for cervical spine stabilization, which is designed to restore disc height and provide stability. This approach may differ from other treatments like artificial discs or zero-profile constructs, which focus on maintaining range of motion and minimizing impact on adjacent disc spaces.12459

Research Team

JG

John German, MD

Principal Investigator

Albany Medical College

Eligibility Criteria

This trial is for adults aged 22-79 with neck pain and spinal issues due to cervical disc disorder, who haven't improved after 6 weeks of non-surgical treatment. Candidates must have specific scores on NDI or mJOA scales, confirmed symptoms by imaging, and be able to consent. Exclusions include prior cervical surgeries at the affected levels, certain bone diseases, severe instability or infection in the spine area, high-dose steroid use, substance abuse history, pregnancy, metal allergies and a BMI over 40.

Inclusion Criteria

I have been diagnosed with nerve or spinal cord issues in my neck.
Ability to speak, read, and understand the IRB approved Informed Consent document.
Willingness to give informed consent for participation in the study.
See 5 more

Exclusion Criteria

I have a fever.
I have neck pain without any nerve or spinal cord issues needing surgery.
Mental illness that, in the opinion of the investigator, would preclude patient's ability to participate in the study.
See 27 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgical Procedure

Participants undergo a 2-level anterior cervical discectomy and fusion (ACDF) with the CEM-Cage and CEM-Plate

Post-operative Evaluation

Participants are evaluated at 4 weeks, 3 months, 6 months, 12 months, 18 months, and 24 months post-operatively. Quality of life scales and adverse events are collected. Radiographs are used to assess implant positioning, integrity, and fusion.

24 months
6 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • CEM-Plate and CEM-Cage
Trial Overview The study tests the safety and effectiveness of CEM-Cage with CEM-Plate in patients needing a two-level anterior cervical discectomy and fusion (ACDF). Fifty participants will undergo ACDF using these devices and will be monitored regularly up to two years post-operation.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Two-Level ACDF with CEM-Plate Anterior Cervical Plating System and CEM-Cage Cervical Interbody System.

Find a Clinic Near You

Who Is Running the Clinical Trial?

ReVivo Medical, Corp.

Lead Sponsor

Trials
1
Recruited
50+

Albany Medical College

Collaborator

Trials
96
Recruited
12,700+

The Cleveland Clinic

Collaborator

Trials
1,072
Recruited
1,377,000+

IGEA

Industry Sponsor

Trials
6
Recruited
170+

Findings from Research

The Perfect-C implant demonstrated significant advantages in surgical efficiency, with shorter operation times, reduced blood loss, and shorter hospital stays compared to both the Zero-P implant and the titanium plate with PEEK cage in a study of 148 patients undergoing ACDF.
The Perfect-C and Zero-P groups showed no cases of heterotopic ossification, while the plate-with-cage group had a 30% occurrence, indicating a potential safety benefit of the Perfect-C implant in preventing this complication.
Comparison among perfect-C®, zero-P®, and plates with a cage in single-level cervical degenerative disc disease.Noh, SH., Zhang, HY.[2018]

References

Cervical spine stabilization by plate-cage. Clinical evaluation. [2016]
Comparison among perfect-C®, zero-P®, and plates with a cage in single-level cervical degenerative disc disease. [2018]
Changes in cervical alignment of Zero-profile device versus conventional cage-plate construct after anterior cervical discectomy and fusion: a meta-analysis. [2022]
Outcomes following 2-level cervical interventions with cage-and-plate, zero-profile, or arthroplasty constructs. [2023]
Effectiveness of cervical zero profile integrated cage with and without supplemental posterior Interfacet stabilization. [2021]
Follow-up of a new titanium cervical plate for fusion of the cervical spine. [2023]
The use of carbon fiber cages in anterior cervical interbody fusion: report of 100 cases. [2022]
Application of a new integrated low-profile anterior plate and cage system in single-level cervical spondylosis: a preliminary retrospective study. [2022]
9.China (Republic : 1949- )pubmed.ncbi.nlm.nih.gov
The use of a hollow polymethylmethacrylate cervical spacer with plating in the treatment of single level cervical disc disease. [2013]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security